Effects of insulin on luteinizing hormone and prolactin secretion and calcium signaling in female rat pituitary cells

Archives of Gynecology and Obstetrics

Volumn 269, Issue 1, 2003, Pages 45-50

  Weiss, J M ^a   Polack, S ^a   Diedrich, K ^a   Ortmann, O ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Ca signaling; DHEA; Insulin; PCOS

Indexed keywords

CALCIUM ION; GONADORELIN; GONADOTROPIN; INSULIN; LUTEINIZING HORMONE; PROLACTIN; PROTIRELIN;

ANIMAL CELL; ARTICLE; CALCIUM SIGNALING; CELL CULTURE; CONTROLLED STUDY; ESTRUS CYCLE; EXOCYTOSIS; FEMALE; GONADOTROPIN SECRETING CELL; HYPERINSULINEMIA; HYPERPROLACTINEMIA; HYPOPHYSIS CELL; INSULIN RESISTANCE; LUTEINIZING HORMONE RELEASE; NONHUMAN; OVARY POLYCYSTIC DISEASE; PROLACTIN RELEASE; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM SIGNALING; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GONADOTROPIN-RELEASING HORMONE; INSULIN; LUTEINIZING HORMONE; MICROSCOPY, FLUORESCENCE; PITUITARY GLAND; PROLACTIN; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; THYROTROPIN-RELEASING HORMONE;

EID: 0242641492     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-003-0506-9     Document Type: Article

References (30)

1. Abdel-Gadir A, Khatim MS, Mowafi RS et al (1992) Implications of ultrasonically diagnosed polycystic ovaries. II. Studies of dynamic and pulsatile hormonal patterns. Hum Reprod 7:458-461
2. Adashi EY, Hsueh AJ, Yen SS (1981) Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells. Endocrinology 108:1441-1449
3. Balen AH (1993) Hypersecretion of luteinizing hormone and the polycystic ovary syndrome. Hum Reprod 8 [Suppl 2]:123-128
4. Belisle S, Menard J (1980) Adrenal androgen production in hyperprolactinemic states. Fertil Steril 33:396-400
5. Bracero N, Zacur HA (2001) Polycystic ovary syndrome and hyperprolactinemia. Obstet Gynecol Clin North Am 28:77-84
6. Brann DW, Mashesh VB (1991) Regulation of gonadotropin secretion by steroid hormones. Front Neuroendocr 12:165-70
7. Clapp DH, Wiebe RH (1983) The effect of hyperprolactinemia on the diurnal variation of adrenal androgens. Fertil Steril 39:749-752
8. Dunaif A, Scott D, Finegood D et al (1996) The insulinsensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:3299-3306
9. Ehrmann DA, Barnes RB, Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322-353
10. Ehrmann DA, Schneider DJ, Sobel BE et al (1997) Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2108-2116
11. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333:853-861
12. Fulghesu AM, Lanzone A, Andreani CL et al (1995) Effectiveness of a somatostatin analogue in lowering luteinizing hormone and insulin-stimulated secretion in hyperinsulinemic women with polycystic ovary disease. Fertil Steril 64:703-708
13. Higuchi K, Nawata H, Maki T et al (1984) Prolactin has a direct effect on adrenal androgen secretion. J Clin Endocrinol Metab 59:714-718
14. Iuomo MJ, Nestler JE (2001) Insulin-lowering drugs in polycystic ovary syndrome. Obstet Gynecol Clin North Am 28:153-164
15. Kawaguchi M, Funabashi T, Kimura F (1998) Insulin-induced hypoglycemia does not impair the surge of luteinizing hormone secretion in the proestrus rat. Neurosci Lett 256:131-134
16. Nestler JE (1997) Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin Reprod Endocrinol 15:111-122
17. Nestler JE, Jakubowicz DJ (1996) Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335:617-623
18. Ortmann O, Merelli F, Stojilkovic SS, Schulz KD, Emons G, Catt KJ (1994) Modulation of calcium signaling and LH secretion by progesterone in pituitary gonadotrophs and clonal pituitary cells. J Steroid Biochem Mol Biol 48:47-54
19. Ortmann O, Bakhit M, Bloh P et al (1995) Ovarian steroids modulate gonadotropin-releasing hormone-induced biphasic luteinizing hormone secretory responses and inositol phosphate accumulation in rat anterior pituitary cells and alpha T3-1 gonadotrophs. J Steroid Biochem Mol Biol 54:101-109
20. Ortmann O, Tomic M, Weiss JM et al (1998) Dual action of androgen on calcium signaling and luteinizing hormone secretion in pituitary gonadotrophs. Cell Calcium 24:223-231
21. Pugeat M, Ducluzeau PH (1999) Insulin resistance, polycystic ovary syndrome and metformin. Drugs 58:41-46
22. Soldani R, Cagnacci A, Yen SS (1994) Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. Eur J Endocrinol 131:641-645
23. Soldani R, Cagnacci A, Paletti AM et al (1995) Modulation of anterior pituitary luteinizing hormone response to gonadotropin-releasing hormone by insulin-like growth factor I in vitro. Fertil Steril 64:634-637
24. Stojilkovic SS, Catt KJ (1995) Expression and signal transduction pathways of gonadotropin-releasing hormone receptors. Recent Prog Horm Res 50:161-205
25. Stojilkovic SS, Stutzin A, Izumi SI et al (1990) Generation and amplification of the cytosolic calcium signal during secretory responses to gonadotropin-releasing hormone. New Biol 2:272-283
26. Thomas AP, Bird GS, Hajnoczky G, Robb-Gaspers LD, Putney JW Jr (1996) Spatial and temporal aspects of cellular calcium signaling. FASEB J 13:1505-1517
27. 2+ release from internal stores controls exocytosis in pituitary gonadotrophs. Neuron 18:121-132
28. Velazquez E, Acosta A, Mendoza SG (1997) Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 90:392-395
29. Willis D, Franks S (1996) Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 80: 3788-3790
30. Xia YX, Weiss JM, Polack S, Diedrich K, Ortmann O (2000) Interactions of insulin-like growth factor I, insulin, and estradiol on GnRH-stimulated luteinizing hormone release from female rat gonadotrophs. Eur J Endocrinol 144:73-79